Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy.

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

“With multiple such rulings now reinforcing passengers’ rights, it’s becoming increasingly clear that wearing old or gifted jewellery should not subject travellers to suspicion ...

Roosevelt's New Deal. In 1952, U.S. President Harry Truman ordered government seizure of the steel industry to avoid a general strike. In 1960, the United States Senate passed the landmark Civil ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

“This rare form of seizure is typically associated with abnormal activity in the brain’s frontal lobe, particularly the supplementary motor area, which is responsible for controlling motor function ...

We used TNP-ATP, a potent purinergic receptor antagonist, and conducted experiments using a mouse model of mesial temporal lobe epilepsy to examine behavioral performance and neural activity patterns.

The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial - The Phase 3 EPIC trial is designed as a single pivotal trial and is intended to ...

Neurona Therapeutics has gained $102m to support the advancement of its investigational cell therapy, NRTX-1001, into Phase III testing for drug-resistant mesial temporal lobe epilepsy (MTLE). The ...

Mesial temporal lobe epilepsy is the most common form of epilepsy. Credit: PonyWang via Getty Images. Neurona Therapeutics has gained $102m to support the advancement of its investigational cell ...

In this study, we aimed to construct ferroptosis-related gene signatures in temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) and explore their diagnostic role in TLE-HS. Methods: The ...

Temporal lobe attention deficit disorder (ADD) is not a recognized medical condition. Some doctors and clinics claim that it is one of seven subtypes of attention deficit hyperactivity disorder ...